Myeloma patients can look forward to a targeted new treatment option on PBS in 2021
- Media releases
- Research
All Jane Blakely knew about leukaemia was that "people who have leukaemia die".
Updates on three novel therapies for the treatment of CLL and SLL.
Thirty-one days after Deborah Henderson had an infusion of her own re-engineered T-cells in September, she was told her aggressive CLL was in remission and she may well be cured.
Dr Anderson was one of the key researchers involved in the discovery of the live-changing drug, venetoclax (Venclexta®).
Deborah Henderson kissed her children goodbye and moved to London in the hope of getting on a clinical trial.
We spoke to Professor Con Tam on the latest in CLL research.
We had an in-depth chat with the Head of Haematology at Concord Repatriation General Hospital in Sydney about her career highlights, lymphoma research news and how her international collaborative group, Women in Lymohonma is instigating change.